Best practices for optimization and validation of flow cytometry‐based receptor occupancy assays-Reference-Cited by-同舟云学术

Best practices for optimization and validation of flow cytometry‐based receptor occupancy assays

Published:2020-12 Issue:1 Volume:100 Page:63-71
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Hilt Ed¹,Sun Yongliang S.¹,McCloskey Thomas W.²,Eck Steve³,McIntosh Thomas⁴,Grugan Katharine D.⁵,Lanham David F.⁶,Standifer Nathan⁷,Green Cherie⁸,Litwin Virginia⁹,Stewart Jennifer J.¹⁰

Affiliation:

1. Bristol Myers Squibb Princeton New Jersey USA

2. ICON Laboratory Services Farmingdale New York USA

3. Integrated Bioanalysis Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland USA

4. Independent Consultant Langhorne Pennsylvania USA

5. Biologics Development Sciences Janssen BioTherapeutics, Janssen R&D, LLC Spring House Pennsylvania USA

6. Eurofins BioPharma Services Abingdon Oxfordshire UK

7. Integrated Bioanalysis Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca South San Francisco California USA

8. Development Sciences Genentech, Inc., A Member of the Roche Group South San Francisco California USA

9. Caprion Biosciences Montreal Quebec Canada

10. Flow Contract Site Laboratory Bothell Washington USA

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21970

Reference32 articles.

1. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

2. Recommendations for the evaluation of specimen stability for flow cytometric testing during drug development

3. Flow cytometric method transfer: Recommendations for best practice

4. Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines ( PART 2 – Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies);Bioanalysis;2024-04-17

2. Flow Cytometry: A Versatile and Powerful Tool for Drug Discovery and Development;Pharmedicine Journal;2024-02-29

3. Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development;Frontiers in Immunology;2023-11-23

4. Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals;Frontiers in Immunology;2022-05-26

5. Progress towards global standardization for quantitative flow cytometry;Bioanalysis;2021-11